Benefits of combination therapy on exacerbations in nonsmoking patients with asthma

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 3, 2008, Pages 780-

  Jackson, Catherine ^a   Lipworth, Brian ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; STEROID;

ASTHMA; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; HUMAN; LETTER; MONOTHERAPY; PRIORITY JOURNAL; SMOKING HABIT; TREATMENT OUTCOME;

ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG COMBINATIONS; HUMANS; SMOKING;

EID: 40049104364     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.12.1144     Document Type: Letter

References (1)

1. Pedersen S.E., Bateman E.D., Bousquet J., Busse W.W., Yoxall S., and Clark T.J. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol 120 (2007) 1036-1042